| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Wyeth-Ayerst Laboratories, Inc. Research (D.L.C., E.M.Q., G.A.M., D.E.B., B.M.-R.), Radnor, Pennsylvania 19101; and Department of Surgery (J.G.K.), Downstate Medical Center, Brooklyn, New York 11203
Address all correspondence and requests for reprints to: Dr. David L. Crandall, Wyeth-Ayerst Laboratories, Inc. Research, P.O. Box 42528, Philadelphia, Pennsylvania 19101. E-mail: crandad{at}war.wyeth.com
To further investigate the role of plasminogen activator inhibitor-1
(PAI-1) in adipose tissue physiology, the production and regulation of
PAI-1 was determined in primary cultures of human preadipocytes. When
expressed as production per cell and cultured under identical
conditions, human preadipocytes from both visceral (omental) and sc
depots of lean and obese individuals released significant, yet similar,
amounts of PAI-1 protein into the conditioned medium. High steady-state
PAI-1 messenger RNA (mRNA) concentrations were observed in visceral and
sc preadipocytes, with the relative level of expression equivalent to
ß-actin mRNA. Tumor necrosis factor
significantly
decreased PAI-1 production in a concentration-dependent manner in both
visceral and sc cultures, whereas transforming growth factor ß
significantly elevated PAI-1 production, but only in sc preadipocytes
from obese individuals. Addition of insulin had no effect on antigen
levels in conditioned medium of preadipocyte cultures. Stimulation of
the preadipocyte cultures with a defined medium resulted in
differentiation to the adipocyte phenotype, as determined by flow
cytometric analysis, verifying the cultures as human preadipocyte.
These studies are the first to observe significant PAI-1 mRNA
expression and protein production in primary cultures of a human
adipose tissue cellular component, and they suggest that nascent
adipocytes contribute significantly to the elevated plasma PAI-1
observed in obesity.
This article has been cited by other articles:
![]() |
S. Zvonic, M. Lefevre, G. Kilroy, Z. E. Floyd, J. P. DeLany, I. Kheterpal, A. Gravois, R. Dow, A. White, X. Wu, et al. Secretome of Primary Cultures of Human Adipose-derived Stem Cells: Modulation of Serpins by Adipogenesis Mol. Cell. Proteomics, January 1, 2007; 6(1): 18 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. De Taeye, T. Novitskaya, L. Gleaves, J. W. Covington, and D. E. Vaughan Bone Marrow Plasminogen Activator Inhibitor-1 Influences the Development of Obesity J. Biol. Chem., October 27, 2006; 281(43): 32796 - 32805. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Crandall, E. M. Quinet, S. El Ayachi, A. L. Hreha, C. E. Leik, D. A. Savio, I. Juhan-Vague, and M.-C. Alessi Modulation of Adipose Tissue Development by Pharmacological Inhibition of PAI-1 Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2209 - 2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Alessi and I. Juhan-Vague PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2200 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Hausman, S. P. Poulos, R. L. Richardson, C. R. Barb, T. Andacht, H. C. Kirk, and R. L. Mynatt Secreted proteins and genes in fetal and neonatal pig adipose tissue and stromal-vascular cells J Anim Sci, July 1, 2006; 84(7): 1666 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rega, C. Kaun, T.W. Weiss, S. Demyanets, G. Zorn, S.P. Kastl, S. Steiner, D. Seidinger, C.W. Kopp, M. Frey, et al. Inflammatory Cytokines Interleukin-6 and Oncostatin M Induce Plasminogen Activator Inhibitor-1 in Human Adipose Tissue Circulation, April 19, 2005; 111(15): 1938 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. H. van Dielen, W. A. Buurman, M. Hadfoune, J. Nijhuis, and J. W. Greve Macrophage Inhibitory Factor, Plasminogen Activator Inhibitor-1, Other Acute Phase Proteins, and Inflammatory Mediators Normalize as a Result of Weight Loss in Morbidly Obese Subjects Treated with Gastric Restrictive Surgery J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4062 - 4068. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bastelica, P. Morange, B. Berthet, H. Borghi, O. Lacroix, M. Grino, I. Juhan-Vague, and M.-C. Alessi Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat: Evidence of Differences Between Visceral and Subcutaneous Deposits Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 173 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Skurk, Y.-M. Lee, and H. Hauner Angiotensin II and Its Metabolites Stimulate PAI-1 Protein Release From Human Adipocytes in Primary Culture Hypertension, May 1, 2001; 37(5): 1336 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Crandall, D. E. Busler, B. McHendry-Rinde, T. M. Groeling, and J. G. Kral Autocrine Regulation of Human Preadipocyte Migration by Plasminogen Activator Inhibitor-1 J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2609 - 2614. [Abstract] [Full Text] |
||||
![]() |
S.-i. Yamagishi, D. Edelstein, X.-l. Du, Y. Kaneda, M. Guzman, and M. Brownlee Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A J. Biol. Chem., June 29, 2001; 276(27): 25096 - 25100. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |